Walleye Capital LLC Makes New $5.67 Million Investment in Maximus, Inc. (NYSE:MMS)

Walleye Capital LLC bought a new position in shares of Maximus, Inc. (NYSE:MMS) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 60,839 shares of the health services provider’s stock, valued at approximately $5,668,000. Walleye Capital LLC owned 0.10% of Maximus as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. Assenagon Asset Management S.A. lifted its holdings in shares of Maximus by 277.0% during the 3rd quarter. Assenagon Asset Management S.A. now owns 878,894 shares of the health services provider’s stock valued at $81,878,000 after purchasing an additional 645,760 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund lifted its holdings in shares of Maximus by 942.9% during the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 323,300 shares of the health services provider’s stock valued at $27,707,000 after purchasing an additional 292,300 shares during the last quarter. Millennium Management LLC lifted its holdings in shares of Maximus by 150.4% during the 2nd quarter. Millennium Management LLC now owns 406,075 shares of the health services provider’s stock valued at $34,801,000 after purchasing an additional 243,890 shares during the last quarter. Algert Global LLC purchased a new stake in shares of Maximus during the 2nd quarter valued at $12,424,000. Finally, Reinhart Partners LLC. lifted its holdings in shares of Maximus by 53.5% during the 2nd quarter. Reinhart Partners LLC. now owns 355,914 shares of the health services provider’s stock valued at $30,502,000 after purchasing an additional 124,095 shares during the last quarter. Hedge funds and other institutional investors own 97.21% of the company’s stock.

Wall Street Analyst Weigh In

Separately, StockNews.com downgraded Maximus from a “buy” rating to a “hold” rating in a research report on Thursday.

Maximus Price Performance

NYSE MMS opened at $74.50 on Monday. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.49 and a quick ratio of 1.49. The stock’s fifty day moving average price is $86.50 and its 200 day moving average price is $87.58. Maximus, Inc. has a 1 year low of $71.75 and a 1 year high of $93.97. The company has a market cap of $4.49 billion, a price-to-earnings ratio of 14.90 and a beta of 0.77.

Maximus Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Saturday, November 30th. Investors of record on Friday, November 15th were given a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.61%. The ex-dividend date of this dividend was Friday, November 15th. Maximus’s payout ratio is 24.00%.

Insider Activity at Maximus

In related news, insider Michelle F. Link sold 1,363 shares of the company’s stock in a transaction on Tuesday, October 1st. The stock was sold at an average price of $92.56, for a total value of $126,159.28. Following the transaction, the insider now directly owns 6,567 shares of the company’s stock, valued at $607,841.52. This represents a 17.19 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.40% of the stock is owned by insiders.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.